Restoration of p53 function leads to tumour regression in vivo-Reference-Cited by-同舟云学术

Restoration of p53 function leads to tumour regression in vivo

Published:2007-01-24 Issue:7128 Volume:445 Page:661-665
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Ventura Andrea,Kirsch David G.,McLaughlin Margaret E.,Tuveson David A.,Grimm Jan,Lintault Laura,Newman Jamie,Reczek Elizabeth E.,Weissleder Ralph,Jacks Tyler

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature05541.pdf

Reference31 articles.

1. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000)

2. Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468–472 (1999)

3. Jain, M. et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102–104 (2002)

4. Fisher, G. H. et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15, 3249–3262 (2001)

5. Pelengaris, S., Khan, M. & Evan, G. I. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321–334 (2002)

Cited by 1561 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells;Journal of Ethnopharmacology;2024-10

2. Mechanisms that clear mutations drive field cancerization in mammary tissue;Nature;2024-09-04

3. The unfolded protein response regulates ER exit sites via SNRPB-dependent RNA splicing and contributes to bone development;The EMBO Journal;2024-08-19

4. Endothelial Immunosuppression in Atherosclerosis : Translational Control by Elavl1/HuR;2024-08-04

5. Demethylzeylasteral exerts potent efficacy against non-small-cell lung cancer via the P53 signaling pathway;Translational Oncology;2024-08